The Deputy of Production and Head of the Research Production Complex of the Pasteur Institute of Iran warned about the aging vaccine production infrastructure at the Razi Institute and the Pasteur Institute, stating that low pricing of domestically produced vaccines and limited financial resources have prevented these two state institutions from having sufficient capability to renovate and upgrade their production lines.
Vaccine Production Infrastructure at 'Razi' and 'Pasteur' Needs Renovation
The Deputy of Production at the Pasteur Institute highlighted the urgent need for renovation of vaccine production facilities at both the Razi Institute and the Pasteur Institute due to aging infrastructure and financial constraints. This situation raises concerns about the capacity to produce vaccines domestically.
👥 Key Players
📰 What Happened
The Deputy of Production at the Pasteur Institute warned about the urgent need to renovate aging vaccine production facilities at both the Razi Institute and the Pasteur Institute due to financial constraints and low pricing of domestically produced vaccines.
- The infrastructure at both institutes is aging and in need of upgrades.
- Financial limitations are hindering the renovation efforts.
💡 Why It Matters
📚 Background
Iran has been focusing on developing its domestic vaccine production capabilities, especially after facing challenges during the COVID-19 pandemic. The ability to produce vaccines locally is seen as vital for national health security.
🏷️ Entities Mentioned
Translated from the original and edited for English readers. View original source →
Translation confidence: 85%